Viridian Therapeutics, Inc. · NASDAQ:VRDN
Tripuraneni Radhika exercised options for 40,000 Viridian Therapeutics, Inc. shares (Form 4)
Traded Aug 14, 2026 · Filed Aug 18, 2026
On Aug 14, 2026, Tripuraneni Radhika (Chief Medical Officer) exercised options for 40,000 Viridian Therapeutics, Inc. shares at US$13.21 for US$528K, leaving 40,000 shares. Filed Aug 18, 2026 (Form 4).
- Options exercised
- 40,000 shares
- Price
- US$13.21
- Value
- US$528K
- Holding after
- 40,000 shares
- Trading plan
- No
- Role
- Chief Medical Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Common Stock | Option exercise | 40,000 | US$13.21 | 40,000 | Direct |
Source
Related
- Viridian Therapeutics, Inc.
- Tripuraneni Radhika
- Viridian Therapeutics, Inc. shareholders
- Form 4 · Tousignant Jennifer · Aug 20, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Aug 20, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Paradigm Biocapital Advisors LP · Aug 14, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026